Patents by Inventor Francois-Xavier Felpin
Francois-Xavier Felpin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230183383Abstract: A method for chemically functionalizing a cellulosic material using a diazo compound, and the functionalized cellulosic materials obtained by the method. The cellulosic materials may be functionalized with a functional groups selected from hydrophobic agents, catalyzing agents, sensing agent, diagnostic agents, printing agents chelating agents, ligands, antioxidants, antimicrobial agents, or drugs. Also, the uses of functionalized cellulosic materials obtained by the method in a variety of applications.Type: ApplicationFiled: May 19, 2021Publication date: June 15, 2023Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -, NANTES UNIVERSITEInventors: François-Xavier FELPIN, Guillaume BRETEL, Erwan LE GROGNEC, Marie DENIS, Samuel CALDERONI
-
Publication number: 20220153776Abstract: The invention relates to an antagonist of CB1 receptor for use in the treatment of a pathologic condition or disorder selected from the group consisting of bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular diseases; nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic disorders; obesity; addiction, dependence, abuse and relapse related disorders; psychiatric and neurological disorders; neurodegenerative disorders; autoimmune hepatitis and encephalitis; pain; reproductive disorders and skin inflammatory and fibrotic diseases.Type: ApplicationFiled: October 7, 2021Publication date: May 19, 2022Inventors: Pier Vincenzo PIAZZA, Monique VALLEE, Giovanni MARSICANO, Francois-Xavier FELPIN, Luigi BELLOCCHIO, Daniela COTA, Jean-Michel REVEST, Sergio VITIELLO, Umberto SPAMPINATO, Rafael MALDONADO
-
Publication number: 20210230211Abstract: The invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 is C1-8 alkyl, C1-8 alkoxy, CN, NO2, amino, COOH, COOCH3, OH, N3, or halogen and R2 is H, OH, C1-8 alkyl, C1-8 alkoxy, C2-C6 alkenyl, halogen, Bn-O—, Bn- optionally substituted, or Ph- optionally substituted.Type: ApplicationFiled: December 1, 2020Publication date: July 29, 2021Inventors: Pier Vincenzo PIAZZA, Monique VALLEE, Francois-Xavier FELPIN, Jean-Michel REVEST, Sandy FABRE
-
Publication number: 20190202857Abstract: The invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 is C1-8 alkyl, C1-8 alkoxy, CN, NO2, amino, COOH, COOCH3, OH, N3, or halogen and R2 is H, OH, C1-8 alkyl, C1-8 alkoxy, C2-C6 alkenyl, halogen, Bn-O—, Bn- optionally substituted, or Ph- optionally substituted.Type: ApplicationFiled: March 11, 2019Publication date: July 4, 2019Inventors: Pier Vincenzo Piazza, Monique Vallee, Francois-Xavier Felpin, Jean-Michel Revest, Sandy Fabre
-
Patent number: 10259839Abstract: The invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 is C1-8 alkyl, C1-8 alkoxy, CN, NO2, amino, COOH, COOCH3, OH, N3, or halogen and R2 is H, OH, C1-8 alkyl, C1-8 alkoxy, C2-C6 alkenyl, halogen, Bn-O—, Bn- optionally substituted, or Ph- optionally substituted.Type: GrantFiled: November 27, 2013Date of Patent: April 16, 2019Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), SC BELENOS, UNIVERSITE DE BORDEAUXInventors: Pier Vincenzo Piazza, Monique Vallee, Francois-Xavier Felpin, Jean-Michel Revest, Sandy Fabre
-
Publication number: 20190071465Abstract: The invention relates to an antagonist of CB1 receptor for use in the treatment of a pathologic condition or disorder selected from the group consisting of bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular diseases; nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic disorders; obesity; addiction, dependence, abuse and relapse related disorders; psychiatric and neurological disorders; neurodegenerative disorders; autoimmune hepatitis and encephalitis; pain; reproductive disorders and skin inflammatory and fibrotic diseases.Type: ApplicationFiled: October 24, 2018Publication date: March 7, 2019Applicants: INSERM (Institut National de la Santé et de la Recherche Médicale), UNIVERSITE DE BORDEAUXInventors: Pier Vincenzo Piazza, Monique Vallee, Giovanni Marsicano, Francois-Xavier Felpin, Luigi Bellocchio, Daniela Cota, Jean-Michel Revest, Sergio Vitiello, Umberto Spampinato, Rafael Maldonado
-
Patent number: 10150793Abstract: The invention relates to an antagonist of CB1 receptor for use in the treatment of a pathologic condition or disorder selected from the group consisting of bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular diseases; nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic disorders; obesity; addiction, dependence, abuse and relapse related disorders; psychiatric and neurological disorders; neurodegenerative disorders; autoimmune hepatitis and encephalitis; pain; reproductive disorders and skin inflammatory and fibrotic diseases.Type: GrantFiled: May 18, 2012Date of Patent: December 11, 2018Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), UNIVERSITE DE BORDEAUXInventors: Pier Vincenzo Piazza, Monique Vallee, Giovanni Marsicano, Francois-Xavier Felpin, Luigi Bellocchio, Daniela Cota, Jean-Michel Revest, Sergio Vitiello, Umberto Spampinato, Rafael Maldonado
-
Patent number: 10040816Abstract: The invention relates to an antagonist of CB1 receptor for use in the treatment of a pathologic condition or disorder selected from the group consisting of bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular diseases; nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic disorders; obesity; addiction, dependence, abuse and relapse related disorders; psychiatric and neurological disorders; neurodegenerative disorders; autoimmune hepatitis and encephalitis; pain; reproductive disorders and skin inflammatory and fibrotic diseases.Type: GrantFiled: February 1, 2016Date of Patent: August 7, 2018Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de BordeauxInventors: Pier Vincenzo Piazza, Monique Vallee, Giovanni Marsicano, Francois-Xavier Felpin, Luigi Bellocchio, Daniela Cota, Jean-Michel Revest, Sergio Vitiello, Umberto Spampinato, Rafael Maldonado
-
Patent number: 9732115Abstract: The invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 is C1-8 alkyl, C1-8 alkoxy, CN, NO2, amino, COOH, COOCH3, OH, N3, or halogen and R2 is H, OH, C1-8 alkyl, C1-8 alkoxy, C2-C6 alkenyl, halogen, Bn-O—, Bn- optionally substituted, or Ph- optionally substituted.Type: GrantFiled: November 27, 2013Date of Patent: August 15, 2017Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), SC BELENOS, Universite de BordeauxInventors: Pier Vincenzo Piazza, Monique Vallee, Francois-Xavier Felpin, Jean-Michel Revest, Sandy Fabre
-
Publication number: 20170226148Abstract: The invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 is C1-8 alkyl, C1-8 alkoxy, CN, NO2, amino, COOH, COOCH3, OH, N3, or halogen and R2 is H, OH, C1-8 alkyl, C1-8 alkoxy, C2-C6 alkenyl, halogen, Bn-O—, Bn- optionally substituted, or Ph- optionally substituted.Type: ApplicationFiled: April 25, 2017Publication date: August 10, 2017Inventors: Pier Vincenzo Piazza, Monique Vallee, Francois-Xavier Felpin, Jean-Michel Revest, Sandy Fabre
-
Patent number: 9657051Abstract: The invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 is C1-8 alkyl, C1-8 alkoxy, CN, NO2, amino, COOH, COOCH3, OH, N3, or halogen and R2 is H, OH, C1-8 alkyl, C1-8 alkoxy, C2-C6 alkenyl, halogen, Bn-O—, Bn- optionally substituted, or Ph- optionally substituted.Type: GrantFiled: November 27, 2013Date of Patent: May 23, 2017Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), SC BELENOS, Universite de BordeauxInventors: Pier Vincenzo Piazza, Monique Vallee, Francois-Xavier Felpin, Jean-Michel Revest, Sandy Fabre
-
Publication number: 20160145294Abstract: The invention relates to an antagonist of CB1 receptor for use in the treatment of a pathologic condition or disorder selected from the group consisting of bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular diseases; nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic disorders; obesity; addiction, dependence, abuse and relapse related disorders; psychiatric and neurological disorders; neurodegenerative disorders; autoimmune hepatitis and encephalitis; pain; reproductive disorders and skin inflammatory and fibrotic diseases.Type: ApplicationFiled: February 1, 2016Publication date: May 26, 2016Inventors: Pier Vincenzo Piazza, Monique Vallee, Giovanni Marsicano, Francois-Xavier Felpin, Luigi Bellocchio, Daniela Cota, Jean-Michel Revest, Sergio Vitiello, Umberto Spampinato, Rafael Maldonado
-
Publication number: 20150284423Abstract: The invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 is C1-8 alkyl, C1-8 alkoxy, CN, NO2, amino, COOH, COOCH3, OH, N3, or halogen and R2 is H, OH, C1-8 alkyl, C1-8 alkoxy, C2-C6 alkenyl, halogen, Bn-O—, Bn- optionally substituted, or Ph- optionally substituted.Type: ApplicationFiled: November 27, 2013Publication date: October 8, 2015Inventors: Pier Vincenzo Piazza, Monique Vallee, Francois-Xavier Felpin, Jean-Michel Revest, Sandy Fabre
-
Publication number: 20140200200Abstract: The invention relates to an antagonist of CB1 receptor for use in the treatment of a pathologic condition or disorder selected from the group consisting of bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular diseases; nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic disorders; obesity; addiction, dependence, abuse and relapse related disorders; psychiatric and neurological disorders; neurodegenerative disorders; autoimmune hepatitis and encephalitis; pain; reproductive disorders and skin inflammatory and fibrotic diseases.Type: ApplicationFiled: May 18, 2012Publication date: July 17, 2014Applicants: UNIVERSITE DE BORDEAUX I, INSERM (Institut National de la Sante et de la Recherche Medicale), UNIV DE BORDEAUX II VICTOR SEGALENInventors: Pier Vincenzo Piazza, Monique Vallee, Giovanni Marsicano, Francois-Xavier Felpin, Luigi Bellocchio, Daniela Cota, Jean-Michel Revest, Sergio Vitiello, Umberto Spampinato, Rafael Maldonado